Pursuant to regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, Sun Pharma Advanced Research Company has informed about submission of the Press Release titled ‘Schrodinger and SPARC Announce Collaboration to Accelerate Neurodegeneration Drug Development Program’ being released by the company, which is self-explanatory.
The above information is a part of company’s filings submitted to BSE.